Evidence map›Paper›PMID 28956284›Full record

ArticleInfection2017

Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience.

Cornelia Lass-Flörl, Maria Aigner, David Nachbaur, Stephan Eschertzhuber, Brigitte Bucher, Christian Geltner, Romuald Bellmann, Michaela Lackner, Dorothea Orth-Höller, Reinhard Würzner and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Infection, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Current and Future Pathways inAntibiotics (Basel, Switzerland) · 2023
    Review
  5. Review
  6. Novel Antifungal Agents and Their Activity againstJournal of fungi (Basel, Switzerland) · 2020
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Cornelia Lass-FlörlDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41/III, 6020, Innsbruck, Tirol, Austria. cornelia.lass-floerl@i-med.ac.at.ORCID http://orcid.org/0000-0002-2946-7785
Maria AignerDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41/III, 6020, Innsbruck, Tirol, Austria.
David NachbaurDivision of Haematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
Stephan EschertzhuberTransplant Intensive Care Unit, Department of Anesthesia and Critical Care, Centre of Operative Medicine, Medical University of Innsbruck, Innsbruck, Austria.
Brigitte BucherDepartment of Pulmonology, Hospital Natters, Natters, Austria.
Christian GeltnerDepartment of Pulmonology, Hospital Natters, Natters, Austria.
Romuald BellmannDivision of Intensive Care and Emergency Medicine, Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria.
Michaela LacknerDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41/III, 6020, Innsbruck, Tirol, Austria.
Dorothea Orth-HöllerDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41/III, 6020, Innsbruck, Tirol, Austria.
Reinhard WürznerDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41/III, 6020, Innsbruck, Tirol, Austria.
Günter WeissDepartment of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
Bernhard GlodnyDepartment of Radiology, University Hospital Innsbruck, Innsbruck, Austria. bernhard.glodny@i-med.ac.at.
Innsbruck Medical University · ATUniversity Hospital Innsbruck · AT

Funding

Austrian Science Fund W1253-B24Christian Doppler Forschungsgesellschaft CD-Laboratory fo Fungal Infections
6 · The paper itself

Abstract

backgroundInvasive fungal diseases (IFD) are an important cause of morbidity and mortality in immunocompromised patients, and early diagnosis and management are a challenge. We evaluated the clinical utility of computed tomography (CT)-guided percutaneous lung biopsies in diagnosing IFD.

methodsBetween 2003 and 2014, we analyzed 2671 CT-guided lung biopsies, from which 157 were IFD associated; we aimed to determine microbiological-based diagnostic accuracy of calcofluor white staining (CFWS), culture, Aspergillus antigen detection (GM), broad-range fungal PCR, and Aspergillus PCR per sample.

results127 (81%) specimens were microscopically positive for any fungal elements, 30 (19%) negative. Aspergillus and non-Aspergillus like hyphae were obtained in 85 (67%) and 42 (33%) specimens, respectively. CFWS positivity was defined as proof of infection. Sensitivity, specificity, and positive (PPV) and negative predictive (NPV) values for CT scan were 100, 44, 80, and 100%, for Aspergillus PCR 89, 58, 88, and 58%, for broad-range fungal PCR 90, 83, 95, and 90%, and for GM 94, 83, 95, and 90%. The most common CT features were patchy opacifications with central necrosis (78%) or cavern defects (50%), less common were air bronchograms (39%) or ground glass halos (39%), and all other features were rare. The overall pneumothorax rate subsequent to biopsy was 19%, but in only 2% of all cases the placement of a chest tube was indicated. One case of fatal air embolism occurred.

conclusionsCT-guided lung biopsies have high diagnostic accuracy in terms of microscopic examination, and complication rates are low. Molecular-based and antigen tests applied on fungal hyphae-positive specimens showed comparable results.

Indexed as

Immunocompromised HostAgedAntigens, FungalAspergillosisAspergillusAustriaBenzenesulfonatesBiopsyFemaleHumansLungLung Diseases, FungalMaleMiddle AgedPolymerase Chain ReactionSpecimen HandlingAntigens, FungalBenzenesulfonatesC.I. Fluorescent Brightening Agent 28AspergillusComputed tomography-guided lung biopsyFungal infectionInvasive fungal diseaseMucormycoses

Identifiers

PMID28956284
PMCPMC5696440
OpenAlexW2760194142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.